Camurus Revenue and Competitors
Estimated Revenue & Valuation
- Camurus's estimated annual revenue is currently $51.1M per year.
- Camurus's estimated revenue per employee is $201,000
Employee Data
- Camurus has 254 Employees.
- Camurus grew their employee count by 5% last year.
Camurus's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Business Development Officer | Reveal Email/Phone |
2 | CEO & Management Assistant | Reveal Email/Phone |
3 | Head Marketing and Communications (UKI) | Reveal Email/Phone |
4 | Head Compliance | Reveal Email/Phone |
5 | VP Regulatory Affairs | Reveal Email/Phone |
6 | Head Medical Affairs | Reveal Email/Phone |
7 | Head Medical Affairs Central Europe | Reveal Email/Phone |
8 | Head Marketing & Business Operations CEU | Reveal Email/Phone |
9 | Head Market Access & Public Policy | Reveal Email/Phone |
10 | Director Business Development & Alliance Management | Reveal Email/Phone |
Camurus Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $17.1M | 85 | 6% | N/A | N/A |
#2 | $51.1M | 254 | 5% | N/A | N/A |
#3 | $24.7M | 123 | 7% | N/A | N/A |
#4 | $86M | 428 | 9% | N/A | N/A |
#5 | $1200M | 1330 | -6% | $2.4B | N/A |
#6 | $4.4M | 22 | -21% | N/A | N/A |
#7 | $9M | 45 | 10% | N/A | N/A |
#8 | $28.5M | 142 | 8% | N/A | N/A |
#9 | $8.8M | 44 | 57% | N/A | N/A |
#10 | $7.6M | 38 | 36% | N/A | N/A |
What Is Camurus?
Camurus is a Swedish research-based pharmaceutical company committed to developing and commercialising innovative and differentiated medicines for the treatment of severe and chronic conditions. New drug products with best-in-class potential are conceived based on the proprietary FluidCrystal® drug delivery technologies and an extensive R&D expertise. Camurus clinical pipeline includes products for treatment of cancer, endocrine diseases, pain and addiction, developed in-house and in collaboration with international pharmaceutical companies. The company's shares are listed on Nasdaq Stockholm under the ticker CAMX.
keywords:N/AN/A
Total Funding
254
Number of Employees
$51.1M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Camurus News
Nanotechnology in Drug Delivery Market Size, Share, Growth 2022-2029| Key Players Access Pharmaceuticals, Alkermes, Aquanova, Camurus.
... for the Forecast Period Between 2022 to 2028: BioDelivery Sciences, Camurus, Carlina Technologies, Cerulean Pharma, Nano Green Sciences.
Camurus : Proposal by the Board on authorization for the Board of Directors to resolve on issues · 1. The authorization may be exercised on one...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $34.1M | 258 | 6% | N/A |
#2 | $59.3M | 327 | -15% | N/A |
#3 | $67.2M | 371 | 19% | N/A |
#4 | $74.9M | 428 | 7% | N/A |
#5 | $215.3M | 492 | -4% | N/A |